Search terms
Results 1 - 10 of 39 - ordered by :
Pages: 1 2 3 4

Choi S. AIMS This study was designed to investigate 6-month clinical outcomes in patients with a very low value of P2Y12 reaction units (PRU) after various antiplatelet agent medication. METHODS AND ...

Date : 06/05/2016 Item size : 31159 bytes

EuroIntervention Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) ...

Date : 20/06/2014 Item size : 35880 bytes

Definition, mechanisms, determination with laboratory tests and clinical implications Burak Pamukçu1, Hüseyin Oflaz2, Yýlmaz Niþancý3 1Department of Cardiology Ýstanbul Medical ...

Date : 12/01/2017 Item size : 36323 bytes

To maximize the effectiveness of therapy and reduce the hazard of bleeding, ischaemic and bleeding risks should be evaluated on an individual basis. 18.1 Percutaneous coronary intervention in stable ...

European Heart Journal, ESC/EACTS Guidelines, Authors/Task Force members, Stephan Windecker, Philippe Kolh, Fernando Alfonso, Jean-Philippe Collet, Jochen Cremer, Volkmar Falk, Gerasimos Filippatos, ...

Date : 01/10/2014

In most countries aspirin was available as an over-the-counter remedy well before its widespread use in cardiovascular disease, which probably contributed to its widespread acceptability. [...]many ...

European Heart Journal, CURRENT OPINION, S. Ben Freedman, Bernard J. Gersh, Gregory Y. H. Lip

Date : 14/03/2015

The platelet as a drug target has spawned a variety of new drugs that have been shown in large-scale randomized trials to improve patient outcomes in acute coronary syndromes and following ...

European Heart Journal, Verstuyft, Céline, Simon, Tabassome, Kim, Richard B.

Date : 01/08/2009 Item size : 734953 bytes

Increasing intensity of guideline compliant therapy at initial assessment was associated with a reduction in death and MI during follow-up in patients with angina and confirmed coronary disease (HR ...

European Heart Journal, Daly, Caroline, Clemens, Felicity, Lopez-Sendon, Jose L., Tavazzi, Luigi, Boersma, Eric, Danchin, Nicholas, Delahaye, Francois, Gitt, Anselm, Julian, Desmond, Mulcahy, David, ...

Date : 01/06/2006 Item size : 259999 bytes

[...]these agents should be used preferentially in high-risk clinical situations prone to atherothrombotic complications including stent thrombosis [e.g. acute coronary syndrome (ACS) patients ...

European Heart Journal, Huber, Kurt

Date : 01/12/2010 Item size : 147702 bytes

In recent years, aspirin has been proscribed for the primary prevention of cardiovascular events in low risk patients because of a small risk for gastrointestinal bleeding and hemorrhagic ...

European Heart Journal, Bates, Eric R, Mukherjee, Debabrata, Lau, Wei C

Date : 01/10/2003 Item size : 103695 bytes

The very justified comment is supported by previous clinical studies.1,2 Our aim of the present manuscript was to provide data on platelet response after administration of 600 mg loading dose of ...

European Heart Journal, Gawaz, Meinrad, Geisler, Tobias

Date : 01/03/2007 Item size : 110830 bytes